Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Stephanie K A Blick"'
Publikováno v:
American Journal of Cardiovascular Drugs. 8:113-125
Fondaparinux sodium (Arixtra) is a synthetic, sulfated pentasaccharide, selective factor Xa inhibitor that is indicated in Europe for preventing thrombus formation in patients with acute coronary syndromes (ACS; the focus of this review), including t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a412aefcdd0b782b92d7e16c0979f96b
https://doi.org/10.1007/bf03256588
https://doi.org/10.1007/bf03256588
Autor:
Gillian M. Keating, Stephanie K A Blick, Kate McKeage, Jamie D. Croxtall, Katherine A. Lyseng-Williamson
Publikováno v:
Drugs. 68:1571-1607
Esomeprazole (Nexium); S-omeprazole) is a single optical isomer proton-pump inhibitor (PPI) approved for the management of reflux oesophagitis, the symptomatic treatment of gastro-oesophageal reflux disease (GORD), the prevention and healing of NSAID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c32326df4756f0b3ed5b1b1e21823f4
https://doi.org/10.2165/00003495-200868110-00009
https://doi.org/10.2165/00003495-200868110-00009
Autor:
Stephanie K A Blick, Monique P Curran
Publikováno v:
BioDrugs. 21:195-201
Certolizumab pegol is a pegylated humanized Fab' fragment of an anti-tumor necrosis factor-alpha (TNFalpha) monoclonal antibody, which binds with high affinity to both membrane-bound and soluble TNFalpha and demonstrates high neutralizing potency for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d24590e31e5b79a63208c9f9442c3c
https://doi.org/10.2165/00063030-200721030-00006
https://doi.org/10.2165/00063030-200721030-00006
Autor:
Lesley J. Scott, Stephanie K A Blick
Publikováno v:
Drugs. 67:2585-2607
Cetuximab (Erbitux) is a human-mouse chimeric monoclonal antibody, which competitively binds to the accessible extracellular domain of the epidermal growth factor receptor (EGFR) to inhibit dimerisation and, subsequently, inhibit tumour growth and me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81179438edd64b78e79a491351904e88
https://doi.org/10.2165/00003495-200767170-00008
https://doi.org/10.2165/00003495-200767170-00008
Publikováno v:
Drugs. 66:2387-2393
▴ The fentanyl buccal tablet (FBT) is a new formulation of fentanyl that uses an effervescent drug delivery system to enhance penetration across the buccal mucosa for the treatment of breakthrough pain in opioid-tolerant patients with cancer. ▴ F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bffa64793c60321e8fbc6cfedf29aab4
https://doi.org/10.2165/00003495-200666180-00013
https://doi.org/10.2165/00003495-200666180-00013
Publikováno v:
BioDrugs. 23:197-199
Recombinant teriparatide (Forteo; Forsteo) is an anabolic (bone-forming) agent. Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a4e7939140daf17efd4a0387ced36f0
https://doi.org/10.2165/00063030-200923030-00006
https://doi.org/10.2165/00063030-200923030-00006
Publikováno v:
BioDrugs. 22:413-415
Fondaparinux sodium (Arixtra) is a synthetic, sulfated pentasaccharide, selective factor Xa inhibitor that is indicated in Europe for preventing thrombus formation in patients with acute coronary syndromes (ACS; the focus of this review), including t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dd91e922961bc59c1c7a260e1ef3995
https://doi.org/10.2165/0063030-200822060-00007
https://doi.org/10.2165/0063030-200822060-00007
Publikováno v:
Drugs. 69(18)
▴ Telavancin is the first available lipoglycopeptide antibacterial agent. It is active against Gram-positive bacteria, including meticillin/oxacillin-resistant Staphylococcus aureus (MRSA) strains associated with complicated skin and skin structure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1330e29309c9ebe0349bce09f0b64417
https://pubmed.ncbi.nlm.nih.gov/19943710
https://pubmed.ncbi.nlm.nih.gov/19943710
Publikováno v:
Drugs. 68(18)
Recombinant teriparatide (Forteo; Forsteo) is an anabolic (bone forming) agent. Studies have shown that subcutaneous teriparatide 20 microg/day is effective in women with postmenopausal osteoporosis, men with idiopathic or hypogonadal osteoporosis an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e8ceecb951d7db156aaf63f1a040a73
https://pubmed.ncbi.nlm.nih.gov/19093708
https://pubmed.ncbi.nlm.nih.gov/19093708
Publikováno v:
Drugs. 67(8)
▴ Ranibizumab is the antigen-binding fragment of a recombinant, humanised monoclonal antibody, which binds with high affinity to, and inhibits the activity of, all active forms of vascular endothelial growth factor A, an important mediator in the d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ea0665d04867b55ff754a3f5bedbcd3
https://pubmed.ncbi.nlm.nih.gov/17521219
https://pubmed.ncbi.nlm.nih.gov/17521219